JP Morgan Private Wealth Advisors’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
AVLSA
GC
ACM
JP Morgan Private Wealth Advisors's TECX Position: Q1 2022 in Review
JP Morgan Private Wealth Advisors sold out of Tectonic Therapeutic (TECX) in Q1 2022, closing a stake of 1,667 shares — an estimated $77K sold.
JP Morgan Private Wealth Advisors first reported a position in TECX in Q2 2020 and held it in 7 quarters. The position peaked at $492K in Q2 2020. 79 funds tracked by Wall St. Rank hold TECX as of Q1 2022.
- JP Morgan Private Wealth Advisors reported no remaining Tectonic Therapeutic position as of Q1 2022 after selling out during the quarter.
- JP Morgan Private Wealth Advisors sold 1,667 Tectonic Therapeutic shares in Q1 2022, an estimated $77K.
- JP Morgan Private Wealth Advisors first reported a position in Tectonic Therapeutic in Q2 2020 and held it in 7 quarters.
- JP Morgan Private Wealth Advisors's Tectonic Therapeutic position peaked at $492K in Q2 2020.
- 79 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.
Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.